New combination therapy exploits ‘natural killer’ cells to destroy head and neck tumours 16 Jun 2022 Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours. Find out more Show/Hide
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers 14 Jun 2022 Discovery Club members gathered at the Science Museum in London to learn how our researchers are transforming cancer care for patients with innovative combination therapies. Find out more Show/Hide
ASCO 2022: 'Practice-changing' radiotherapy technique can reduce swallowing problems for cancer patients 13 Jun 2022 A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term side effects, including swallowing problems, for patients with head and neck cancer following treatment. Find out more Show/Hide
New head and neck cancer radiotherapy technique could deliver more robust treatment plan in shorter time on MR Linac 23 May 2022
ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers 11 Oct 2021
ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’ 07 Sep 2020
ASCO 2020: New optimised precision radiotherapy can reduce swallowing difficulties for head and neck cancer patients 30 May 2020
The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer 15 Jan 2020